Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918265041513 (International callers) or +918265041513 (Indian callers).
Clavam 625mg is a prescription antibiotic containing Amoxicillin 500 mg and Clavulanic Acid 125 mg. It belongs to the penicillin class of antibiotics and is used to treat a wide range of bacterial infections caused by susceptible organisms, including those that produce beta-lactamase enzymes. Clavulanic acid protects amoxicillin from bacterial resistance, improving its effectiveness against difficult-to-treat infections.
Product Specifications
Brand Name
Clavam 625mg
Generic Name
Amoxicillin + Clavulanic Acid (Co-Amoxiclav)
Strength
Amoxicillin 500 mg + Clavulanic Acid 125 mg
Dosage Form
Film-Coated Tablet
Therapeutic Class
Broad-Spectrum Penicillin Antibiotic
Route of Administration
Oral
Prescription Status
Prescription Only Medicine (POM)
Common Pack Size
10 or 15 Tablets (varies by manufacturer)
Storage
Store below 25°C in a cool, dry place, protected from moisture
Key Features
Contains 500 mg Amoxicillin and 125 mg Clavulanic Acid.
Effective against a broad spectrum of Gram-positive and Gram-negative bacteria.
Helps overcome bacterial resistance caused by beta-lactamase-producing organisms.
Commonly prescribed for respiratory, ear, sinus, urinary tract, skin, soft tissue, and dental infections.
Best taken with food to reduce stomach upset and improve tolerance.
Patients should complete the full prescribed course, even if symptoms improve early, to reduce the risk of recurrence and antibiotic resistance.
Industry Update
Sheffield and the wider Yorkshire region continue to see consistent demand for Co-Amoxiclav 625 mg due to its important role in treating community-acquired bacterial infections. NHS antimicrobial stewardship programmes continue to encourage healthcare professionals to prescribe antibiotics only when clinically appropriate, helping reduce antimicrobial resistance while maintaining access for patients who need treatment.
Hospitals and community pharmacies across Yorkshire maintain reliable supplies of generic co-amoxiclav formulations from multiple approved manufacturers, supporting uninterrupted patient access. Healthcare providers are increasingly guided by culture results and local prescribing guidelines to ensure responsible antibiotic use, while emphasizing patient education on completing prescribed treatment courses.
Chat with us
Chat with us
